XELJANZ (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate Biotech Investing
Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke Biotech Investing
Significant Bioavailability Results in Human Clinical Trial using Lexaria’s DehydraTECH (TM) Powered TurboCBD (TM) Capsules Biotech Investing
Isodiol International Inc. Introduces Isoderm Direct Effects Technology Nationally Via PBS Television Biotech Investing
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation Biotech Investing
